Paul J. Hastings, Director at Pacira BioSciences, Inc. (PCRX), sold 4,050 shares at $47.46 ($192K) on 2020-06-04, disclosed to the SEC on 2020-06-08.
Seasonal sale ($192k) by Director — this insider has traded PCRX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.46 | 2,025 | $96K | 50.0% |
| 2 | $47.46 | 2,025 | $96K | 50.0% |
| Total | $47.46 avg | 4,050 | $192K | 100% |
| Filing → |
| NKTX | SELL | 2025-06-20 | $3K | — | Filing → |
| NKTX | SELL | 2025-01-17 | $38K | — | Filing → |
| NKTX | SELL | 2024-06-20 | $10K | — | Filing → |